Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.706236
Title: Biochemical and biophysical studies to characterise the Ras:Sos:nucleotide interactions
Author: Vo, Uybach
ISNI:       0000 0004 6056 5556
Awarding Body: University of Manchester
Current Institution: University of Manchester
Date of Award: 2015
Availability of Full Text:
Access through EThOS:
Access through Institution:
Abstract:
Ras proteins are mutated in 30% of all human tumours contributing to several malignant phenotypes including abnormal cell growth, proliferation and apoptosis. The activity of Ras is controlled by the inter-conversion between GTP- and GDP- bound forms. This conversion is partly regulated by the binding of protein Son of Sevenless (Sos), a guanine nucleotide exchange factor. The mechanism of Ras activation via its interactions with Sos remains unclear making it challenging as an effective drug target. The aim of this work is to use Nuclear Magnetic Resonance (NMR) spectroscopy and other biophysical methods to understand the molecular activation of Ras via its interactions with Sos. In this thesis, the backbone and Cβ, as well as the partial side-chain NMR assignment for human K-Ras•GDP were completed at pH 7.4. We also revealed significant chemical shift differences between apo, GDP and GTPϒS-bound H-Ras states from the TROSY spectra. In addition, the monitoring of shift perturbations for H-Ras reveals several residues that appear to be central in Sos binding and may provide a starting point in the search for possible inhibition sites for future drug design. To gain a further understanding into the binding events of the Ras:Sos complex, we have expressed and purified the Sos construct containing the REM and Cdc25 domains (SosCat) for titration studies. Here, we have implemented a relatively novel approach to study large complexes (Stoffregen et al. 2012), by selectively labelling the [13C-] Met and Ile methyl groups of SosCat. This approach has provided an assignment for eight reporter signals. In addition, monitoring the shift perturbations of Met [13C-] methyls in the NMR spectra allowed us to examine individual residues at the two Ras binding sites (allosteric and catalytic sites) of SosCat. Disruption of H-Ras•GTPγS binding at the allosteric site (via SosCat W729E mutant) significantly weakens the interactions of Ras at the catalytic site. The data suggests a positive co-operative binding mechanism between the allosteric and catalytic sites, which is consistent with the allosteric feedback model. We have also measured the binding affinities of SosCat (by NMR spectroscopy and fluorescence) with wild type and Ras mutants using different GTP analogues. Our 15N-relaxation data of the H-Ras•GTPϒS:SosCat complex reveal dynamical changes in several regions of Ras other than the P-loop, switch I and II regions. In addition, the backbone NMR relaxation studies revealed that a complex between H-Ras•GTPϒS and SosCat proteins is dynamic and transiently formed. The reported work could be a significant step towards understanding the activation of Ras via its interactions with Sos; and in time the data may influence new anti-cancer treatments.
Supervisor: Not available Sponsor: AstraZeneca ; Medical Research Council
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.706236  DOI: Not available
Keywords: Ras ; Sos
Share: